Fonar Corporation (NASDAQ:FONR – Get Free Report) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totaling 79,190 shares, a growth of 90.7% from the April 15th total of 41,536 shares. Currently, 1.4% of the shares of the company are sold short. Based on an average daily volume of 58,606 shares, the short-interest ratio is currently 1.4 days.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Fonar in a research report on Tuesday, April 7th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Fonar currently has a consensus rating of “Hold”.
View Our Latest Stock Analysis on Fonar
Fonar Trading Up 0.0%
Fonar (NASDAQ:FONR – Get Free Report) last released its earnings results on Monday, May 11th. The medical equipment provider reported $0.24 earnings per share (EPS) for the quarter. Fonar had a net margin of 6.35% and a return on equity of 4.12%. The company had revenue of $26.47 million for the quarter.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of FONR. CIBC Private Wealth Group LLC acquired a new stake in Fonar in the 3rd quarter valued at about $90,000. PenderFund Capital Management Ltd. acquired a new position in shares of Fonar during the fourth quarter worth about $150,000. Inspire Advisors LLC purchased a new stake in shares of Fonar during the third quarter worth approximately $216,000. Ritholtz Wealth Management raised its holdings in Fonar by 66.4% in the third quarter. Ritholtz Wealth Management now owns 17,417 shares of the medical equipment provider’s stock valued at $262,000 after acquiring an additional 6,948 shares in the last quarter. Finally, Empowered Funds LLC raised its holdings in Fonar by 7.7% in the first quarter. Empowered Funds LLC now owns 21,139 shares of the medical equipment provider’s stock valued at $296,000 after acquiring an additional 1,504 shares in the last quarter. 50.64% of the stock is currently owned by hedge funds and other institutional investors.
Fonar Company Profile
Fonar Corporation is a medical technology company primarily engaged in the design, manufacture and sale of magnetic resonance imaging (MRI) systems. The company’s flagship product, the UPRIGHT® Multi-Position™ MRI, enables patients to be scanned in standing, seated and traditional recumbent positions, offering enhanced diagnostic capabilities for musculoskeletal, neurological and vascular conditions. In addition to MRI equipment sales, Fonar provides equipment installation, training and maintenance services to hospitals, imaging centers and private practices.
Headquartered in Melville, New York, Fonar markets its MRI systems both domestically and internationally, supported by a network of service engineers and customer support personnel.
Recommended Stories
- Five stocks we like better than Fonar
- Flipping the Switch: Is Ford the Next Big Energy Stock?
- Does Nano Nuclear Energy’s New Deal Amp the Outlook?
- 3 Dividend Stocks With Insiders Buying in 2026
- Dillard’s Posted a Huge Earnings Beat—So Why Did the Rally Fade?
Receive News & Ratings for Fonar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fonar and related companies with MarketBeat.com's FREE daily email newsletter.
